Matches in DBpedia 2015-10 for { ?s ?p "Ficlatuzumab is a humanized monoclonal antibody designed for the treatment of cancers.Ficlatuzumab was developed by AVEO Pharmaceuticals. In May 2012, AVEO released results of a Phase II clinical trial comparing gefitinib alone and in combination with ficlatuzamab in treatment-naive Asian patients with non-small cell lung cancer."@en }
Showing triples 1 to 2 of
2
with 100 triples per page.
- Ficlatuzumab abstract "Ficlatuzumab is a humanized monoclonal antibody designed for the treatment of cancers.Ficlatuzumab was developed by AVEO Pharmaceuticals. In May 2012, AVEO released results of a Phase II clinical trial comparing gefitinib alone and in combination with ficlatuzamab in treatment-naive Asian patients with non-small cell lung cancer.".
- Ficlatuzumab comment "Ficlatuzumab is a humanized monoclonal antibody designed for the treatment of cancers.Ficlatuzumab was developed by AVEO Pharmaceuticals. In May 2012, AVEO released results of a Phase II clinical trial comparing gefitinib alone and in combination with ficlatuzamab in treatment-naive Asian patients with non-small cell lung cancer.".